USMV vs XBI
iShares MSCI USA Min Vol Factor ETF vs SPDR S&P Biotech ETF
- • USMV has the lower expense ratio at 0.15% vs 0.35% for XBI.
- • USMV pays a higher dividend yield (1.55%).
Side-by-side metrics
| Metric | USMV | XBI |
|---|---|---|
Expense ratio Annual fee. Lower is better. | 0.15% | 0.35% |
Dividend yield Trailing 12-month yield. | 1.55% | 0.34% |
AUM Assets under management — bigger funds are typically more liquid. | $22.86B | $8.30B |
YTD return | 0.23% | 12.92% |
1-year return | — | — |
3-year return Annualized. | — | — |
5-year return Annualized. | — | — |
10-year return Annualized. | — | — |
Beta (3Y) Volatility relative to the market. Closer to 1 = market-like. | 0.50 | 1.09 |
P/E ratio | 22.96 | — |
Last price | $94.28 | $133.66 |
Inception | — | — |
Issuer | iShares | State Street |
USMV top holdings
| CSCO | Cisco Systems Inc | 1.81% |
| NVDA | NVIDIA Corp | 1.64% |
| XOM | Exxon Mobil Corp | 1.60% |
| MSFT | Microsoft Corp | 1.56% |
| DUK | Duke Energy Corp | 1.55% |
| SO | Southern Co | 1.53% |
| APH | Amphenol Corp Class A | 1.50% |
| CB | Chubb Ltd | 1.49% |
| VZ | Verizon Communications Inc | 1.49% |
| WM | Waste Management Inc | 1.47% |
XBI top holdings
| APLS | Apellis Pharmaceuticals Inc | 1.87% |
| RVMD | Revolution Medicines Inc Ordinary Shares | 1.65% |
| TVTX | Travere Therapeutics Inc Ordinary Shares | 1.62% |
| ARWR | Arrowhead Pharmaceuticals Inc | 1.44% |
| TWST | Twist Bioscience Corp | 1.42% |
| SMMT | Summit Therapeutics Inc Ordinary Shares | 1.40% |
| ALKS | Alkermes PLC | 1.38% |
| TGTX | TG Therapeutics Inc | 1.37% |
| MDGL | Madrigal Pharmaceuticals Inc | 1.36% |
| BEAM | Beam Therapeutics Inc | 1.32% |
About USMV
USMV (iShares MSCI USA Min Vol Factor ETF) is US stocks selected for lower volatility. Managed by iShares, the fund carries $22.9B in assets under management, an expense ratio of 0.15%, a dividend yield of 1.55%. Its largest holding is Cisco Systems Inc (CSCO), which represents 1.8% of the portfolio. Real Estate is the fund's largest sector exposure at 2.2%.
About XBI
XBI (SPDR S&P Biotech ETF) is Equal-weight biotech stocks in the S&P Biotech Index. Managed by State Street, the fund carries $8.3B in assets under management, an expense ratio of 0.35%, a dividend yield of 0.34%. Its largest holding is Apellis Pharmaceuticals Inc (APLS), which represents 1.9% of the portfolio. Financial Services is the fund's largest sector exposure at 0.2%.